Charmacy (2289) Announces Proposed Abolishment of Board of Supervisors and Amendments to Key Governance Documents

Bulletin Express

Oct 20, 2025

Charmacy Pharmaceutical Co., Ltd. (Stock Code: 2289) unveiled a plan to discontinue its Board of Supervisors, subject to shareholder approval at an upcoming extraordinary general meeting. According to the announcement dated 20 October 2025, the supervisory functions under the People’s Republic of China Company Law would be absorbed by the Audit Committee of the company’s Board of Directors. Once approved, current Supervisors’ positions and the relevant procedures will be dissolved.

Alongside this proposed change, the company intends to amend its Articles of Association and related internal governance policies. All references to “Supervisors” and the “Board of Supervisors” will be removed, and certain supervisory powers will be reassigned to the Audit Committee. The amendments shall take effect once shareholders vote in favor of the resolution at the extraordinary general meeting.

Charmacy Pharmaceutical Co., Ltd. plans to distribute a circular to shareholders detailing the proposed abolishment of the Board of Supervisors and corresponding updates to the Articles of Association as well as related policies. These measures aim to align the company’s governance structure with the most recent legal and regulatory requirements.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1128827195"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1128827195\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1128827195?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-20 18:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1128827195","market":"hk","top_or_hot":-1,"title":"Charmacy (2289) Announces Proposed Abolishment of Board of Supervisors and Amendments to Key Governance Documents","media":"Bulletin Express","content":"<p>Charmacy Pharmaceutical Co., Ltd. (Stock Code: 2289) unveiled a plan to discontinue its Board of Supervisors, subject to shareholder approval at an upcoming extraordinary general meeting. According to the announcement dated 20 October 2025, the supervisory functions under the People’s Republic of China Company Law would be absorbed by the Audit Committee of the company’s Board of Directors. Once approved, current Supervisors’ positions and the relevant procedures will be dissolved.</p>\n<p>Alongside this proposed change, the company intends to amend its Articles of Association and related internal governance policies. All references to “Supervisors” and the “Board of Supervisors” will be removed, and certain supervisory powers will be reassigned to the Audit Committee. The amendments shall take effect once shareholders vote in favor of the resolution at the extraordinary general meeting.</p>\n<p>Charmacy Pharmaceutical Co., Ltd. plans to distribute a circular to shareholders detailing the proposed abolishment of the Board of Supervisors and corresponding updates to the Articles of Association as well as related policies. These measures aim to align the company’s governance structure with the most recent legal and regulatory requirements.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Charmacy (2289) Announces Proposed Abolishment of Board of Supervisors and Amendments to Key Governance Documents</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCharmacy (2289) Announces Proposed Abolishment of Board of Supervisors and Amendments to Key Governance Documents\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-10-20 18:22</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Charmacy Pharmaceutical Co., Ltd. (Stock Code: 2289) unveiled a plan to discontinue its Board of Supervisors, subject to shareholder approval at an upcoming extraordinary general meeting. According to the announcement dated 20 October 2025, the supervisory functions under the People’s Republic of China Company Law would be absorbed by the Audit Committee of the company’s Board of Directors. Once approved, current Supervisors’ positions and the relevant procedures will be dissolved.</p>\n<p>Alongside this proposed change, the company intends to amend its Articles of Association and related internal governance policies. All references to “Supervisors” and the “Board of Supervisors” will be removed, and certain supervisory powers will be reassigned to the Audit Committee. The amendments shall take effect once shareholders vote in favor of the resolution at the extraordinary general meeting.</p>\n<p>Charmacy Pharmaceutical Co., Ltd. plans to distribute a circular to shareholders detailing the proposed abolishment of the Board of Supervisors and corresponding updates to the Articles of Association as well as related policies. These measures aim to align the company’s governance structure with the most recent legal and regulatory requirements.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02289","symbol_name":"创美药业","start_time":0,"source_url":"","article_id":"1128827195","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1128827195","pubTimestamp":1760955732,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Charmacy Pharmaceutical Co., Ltd. (Stock Code: 2289) unveiled a plan to discontinue its Board of Supervisors, subject to shareholder approval at an upcoming extraordinary general meeting. According...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02289":"创美药业"},"translate_title":"Charmacy(2289)公布建议撤销监事会及修订主要管治文件","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02289":1},"content_text":"Charmacy Pharmaceutical Co., Ltd. (Stock Code: 2289) unveiled a plan to discontinue its Board of Supervisors, subject to shareholder approval at an upcoming extraordinary general meeting. According to the announcement dated 20 October 2025, the supervisory functions under the People’s Republic of China Company Law would be absorbed by the Audit Committee of the company’s Board of Directors. Once approved, current Supervisors’ positions and the relevant procedures will be dissolved.\nAlongside this proposed change, the company intends to amend its Articles of Association and related internal governance policies. All references to “Supervisors” and the “Board of Supervisors” will be removed, and certain supervisory powers will be reassigned to the Audit Committee. The amendments shall take effect once shareholders vote in favor of the resolution at the extraordinary general meeting.\nCharmacy Pharmaceutical Co., Ltd. plans to distribute a circular to shareholders detailing the proposed abolishment of the Board of Supervisors and corresponding updates to the Articles of Association as well as related policies. These measures aim to align the company’s governance structure with the most recent legal and regulatory requirements.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}